ঔষধের বিস্তারিত বা বিকল্প ঔষধ জানতে ঔষধের নাম দিয়ে সার্চ দিন। যেমন- Napa বা Alatrol বা Amodis
Mebhydrolin Napadisylate
Indications Allergic disease or symptoms such as urticaria, pruritus of various origin, eczema, itching, drug rash, insect bites, allergic conjunctivitis, dermatitis of nutritional origin, hay fever, vasomotor rhinitis, allergic asthma.
Therapeutic Class Sedating Anti-histamine
Pharmacology Mebhydrolin is an ethylenediamine derivative antihistamine with antimuscarinic and sedative properties.
Dosage & Administration Adult: 100-300 mg/day or 2-6 tablets daily. Child: 2-5 year: 50-150 mg/day or 1-3 tablets daily; 5-10 year: 100-200 mg/day or 2-4 tablets daily; >10 year: 100-300 mg/day or 2-6 tablets daily. Treatment should be given in several single doses daily. Mebhydrolin may be swallowed during or shortly after meals. For children, the tablet may be crushed and mixed with food.
Interaction Enhanced sedation with alcohol or other CNS depressants. Additive antimuscarinic effects with MAOIs, atropine, TCAs. May mask warning symptoms caused by ototoxic agents e.g. aminoglycoside antibiotics.
Contraindications Hypersensitivity to any of the ingredients of Mebhydrolin tablet or to mebhydrolin, prostatic hypertrophy, narrow-angle glaucoma, first trimester of pregnancy
Side Effects Lassitude, dizziness, hypotension, muscular weakness, nausea, vomiting, diarrhoea or constipation, epigastric pain, headache, blurred vision, tinnitus, depression, nightmares, anorexia, dryness of the mouth, tightness of the chest, tingling, sedation, drowsiness etc. may occur.
Pregnancy & Lactation Safety in pregnancy and lactation has not been established.
Precautions & Warnings Closed-angle glaucoma; urinary retention, prostatic hyperplasia or pyloroduodenal obstruction; epilepsy. Elderly. Pregnancy. May impair ability to drive or operate machinery.
Use in Special Populations Safety in pregnancy and lactation has not been established.